WeedMD Inc. (‘WeedMD’ or the ‘Company’) announced that it has reallocated all medical packaging, labelling and distribution activities from its Bowmanville, Ontario site to its Aylmer, Ontario facility which also houses the Company's extraction hub. These strategic steps are part of WeedMD's ongoing plan to maximize the utilization of its facilities, improve operational efficiencies and further align its cost structure while focusing on growth, following the successful integration of WeedMD and Starseed Holdings Inc. (‘Starseed’). These structural changes, completed in January 2021, now centralize production activities at WeedMD's London-area sites, which also includes the Company's cultivation centre of excellence in Strathroy, Ontario. With the exiting of its Bowmanville facility, which served as WeedMD's medical distribution hub, the Company has offered relocation and severance packages, where applicable, to about 20 employees. WeedMD confirms that all Starseed patient orders began shipping from the Company's Aylmer facility, commencing January 4th, 2021. Visit Starseed here for more information about their medical product offerings.